Addict to win? A different approach to doping

Journal of Medical Ethics

Volumn 36, Issue 11, 2010, Pages 700-707

  D'Angelo, Carlos ^a   Tamburrini, Claudio ^b  

^a Prevention of Drug Abuse and Fight of Drug Trafficking within the Argentinean Government   (Argentina)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ARTICLE; ATTITUDE; BIOETHICS; COMPETITIVE BEHAVIOR; DOPING; ETHICS; HUMAN; PSYCHOLOGICAL ASPECT; SPORT;

ATTITUDE; BEHAVIOR, ADDICTIVE; BIOETHICAL ISSUES; COMPETITIVE BEHAVIOR; DOPING IN SPORTS; HUMANS; SPORTS;

EID: 78049404028     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/jme.2009.034801     Document Type: Article

References (26)

1. D'Angelo C. "¿Es deporte el alto rendimiento?"["Is high performance sports really sports?"]. Revista Hablemos 2007;15:32-8.
2. Tamburrini C. "What's Wrong with Doping?"The "Hand of God"?-Essays in the Philosophy of Sports.Göteborg: Acta Universitatis Gothoburgensis, 2000:34-62.
3. ONU, series of technical reports, 1957; No. 116 and 117.
4. D'Angelo C. "Aspectos ético-legales del doping: Prevención, legislacióny sanciones". In: Milano M, Menéndez G, eds. Manual de Farmacología del Doping. Buenos Aires: Editorial Alfabeta, 1998.
5. Anon. Canada's Drug Strategy, Phase II, Canadian Heritage. Sport Canada: Government of Canada, 1998.
6. UNODOC (United Nations Office on Drugs and Crime). Principles of Drug Dependence Treatment, WHO, 2009. Discussion paper.
7. Anon. Investing in Drug Abuse Treatment. A Discussion Paper for Policy Makers. NY: United Nations. Office on Drugs and Crime, 2003.
8. Beck J. 100 years of "just say no"versus "just say know". Eval Rev 1996;20:596-618.
9. Jacobs D. Evidence for a common dissociative-like reaction among addicts. Journal of Gambling Behaviour 1988;4:27-37.
10. http://www.wada-ama.org/en/about-Wada/. (accessed 17 Sep 2010).
11. http://www.wada-ama.org. (accessed 17 Sep 2010).
12. Rogers SJ, Ruefli T. Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users? Harm Reduct J 2004;1:7. http://www.harmreductionjournal.com/content/1/17. (accessed 17 Sep 2010).
13. Parnell S. Harm reduction as public health strategy. Heartland Perspectives, 2005. http://www.heartland.org/. (accessed 17 Sep 2010).
14. Erickson PG, Riley DM, Cheung YW, et al, eds. Harm reduction: a new direction for drug policies and programs. Toronto, Ontario, Canada: University of Toronto Press, 1997.
15. Nordt C, Stohler R. Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet 2006;367:1830-4.
16. Harper C, Henderson J, Darney P. Abortion in the United States. Annu Rev Public Health 2005;26:501-12.
17. WADA play true report-2008 adverse analytical findings. http://stage.WADAama.org/documents/science_medicine/WADA_laboStatistics_2008.pdf. (accessed 17 Sep 2010).
18. Lash C. The culture of narcissism. New York: W.W. Norton & Company Inc, 1978.
19. Shermer M. The doping dilemma. Scientific American Magazine 2008.
20. Teetzel S. Sharing the blame: complicity, conspiracy and collective responsibility in sport. Acta Universitatis Palackianane Olomucensis. Gymnica 2006;36:85-3.
21. Breivik G. Studies of doping-doping in sport from a sociocultural and ethical perspective. Skrifter I utvalg, blind 4. Norges Idrettshøgskola, 1999:85-3.
22. Kayser B, Mauron A, Miah A. Current anti-doping policy: a critical appraisal. BMC Med Ethics 2007;8:2. http://biomedcentral.com/1472-6939/8/2. (accessed 17 Sep 2010).
23. D'Angelo C. Doping y algo más (Doping and something more). Buenos Aires: Editorial Dunken, Argentina, 2006.
24. Foddy B, Savulescu J. Ethics of performance enhancement in sport: drugs and gene doping. In: Ashcroft RE, Dawson A, Draper H, et al, eds. Principles of Heath Care Ethics. 2nd edn. London: John Wiley and Sons, Ltd, 2007.
25. European Elite Athletes Association. EU athletes' issues-doping. http://www.euathletes.info/home/, (accessed 11 Nov 2008).
26. Lundby C. Testing for recombinant erythropoietin in urine: problems associated with current anti doping testing. J Appl Physiol, 2008;105:417-19.